Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Teva to pay $225 mln, divest cholesterol drug to settle price-fixing charges | Reuters
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva, Drugmakers in Talks With U.S. to End Generics Probes - Bloomberg
Teva Pharmaceuticals at heart of major price fixing suit in US – www.israelhayom.com
Teva shares surge after announcing global opioid settlement
Teva Faces New Class Action—But Could It Afford Another Se...
Teva Pharmaceutical | PBS NewsHour
Israeli drugmaker Teva to cut quarter of global work force (Update)
Teva Forecasts Growth After Expected Actavis Deal Closes | Stock News & Stock Market Analysis - IBD
Teva taps new CFO, hikes legal set-aside to more than $1B as opioid deal falters | Fierce Pharma
Teva Pharm Expects About 25 Percent of EpiPen Market by Year End
Teva Pharmaceutics USA acquires three buildings for an R&D campus in West Chester - Philadelphia Business Journal
Jewish Values Investors JLens Target Israeli Company
Teva shares surge after announcing global opioid settlement
$135 Million Settlement in Illinois AWP Litigation Against Teva Pharmaceuticals USA, Inc. | Miner, Barnhill & Galland, P.C.
Teva Restructuring Coming Together, Rebuilding Confidence in the Company | BioSpace
Teva Pharmaceutical Industries – The Forward
Articles about Teva Pharmaceuticals, Inc.
Jerusalem, Israel. 21st Oct, 2019. The Teva Pharmaceutical logo is seen in English and Hebrew at
Teva Pharmaceuticals Q2 2019 earnings preview | AlphaStreet
Teva's Small Print Gives Rise to Optimism | Ctech
Teva | Partnership | Direct Relief
Teva Pharmaceuticals Recalls Acute Myeloid Leukemia Drug Over Particulate Matter Contamination - Top Class Actions
Jerusalem, Israel. 21st Oct, 2019. The Teva Pharmaceutical logo is seen in English and Hebrew at their tablet production plant in Jerusalem, on Monday, October 21, 2019. The Israeli drug manufacturer Teva's shares have plummeted in recent months over ...
Teva Pharmaceuticals Agrees To $85 Million Settlement With Oklahoma In Opioid Case | KPBS Public Media
